-
Mashup Score: 3
Type 2 diabetes mellitus (T2DM) represents a major health issue worldwide, as patients with T2DM show an excess risk of death for cardiovascular causes, twice as high as the general population. Among the many complications of T2DM, heart failure (HF) deserves special consideration as one of the leading causes of morbidity and reduced life expectancy. T2DM has been associated with different…
Source: Heart Failure ReviewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1
The therapeutic landscape for cardiac amyloidosis is rapidly evolving. In the last decade, our focus has shifted from dealing with the inevitable complications of continued extracellular infiltration of amyloid fibrils to earlier identification of these patients with prompt initiation of targeted therapy to prevent further deposition. Although much of the focus on novel targeted therapies is…
Source: Heart Failure ReviewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 12
The therapeutic landscape for cardiac amyloidosis is rapidly evolving. In the last decade, our focus has shifted from dealing with the inevitable complications of continued extracellular infiltration of amyloid fibrils to earlier identification of these patients with prompt initiation of targeted therapy to prevent further deposition. Although much of the focus on novel targeted therapies is…
Source: Heart Failure ReviewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 11
The therapeutic landscape for cardiac amyloidosis is rapidly evolving. In the last decade, our focus has shifted from dealing with the inevitable complications of continued extracellular infiltration of amyloid fibrils to earlier identification of these patients with prompt initiation of targeted therapy to prevent further deposition. Although much of the focus on novel targeted therapies is…
Source: Heart Failure ReviewsCategories: Hematologists1, Latest HeadlinesTweet
-
Mashup Score: 0
The therapeutic landscape for cardiac amyloidosis is rapidly evolving. In the last decade, our focus has shifted from dealing with the inevitable complications of continued extracellular infiltration of amyloid fibrils to earlier identification of these patients with prompt initiation of targeted therapy to prevent further deposition. Although much of the focus on novel targeted therapies is…
Source: Heart Failure ReviewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 2
Myocardial fibrosis is a common feature of several heart diseases. The progressive deposition of extracellular matrix due to a persistent injury to cardiomyocytes may trigger a vicious cycle that leads to persistent structural and functional alterations of the myocardium. Some drugs (like renināangiotensināaldosterone system inhibitors) have been shown to reduce extracellular matrix deposition,…
Source: Heart Failure ReviewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0
Frequent premature ventricular contractions (PVCs) associated left ventricular systolic dysfunction (LVSD) is a well-known clinical scenario and numerous predictors for cardiomyopathy (CMP) development have been already thoroughly described. It may present as a “pure” form of dissynchrony-induced cardiomyopathy or it may be an aggravating component of a multifactorial structural heart disease….
Source: Heart Failure ReviewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients - Heart Failure Reviews - 3 year(s) ago
Alterations of endothelial function, inflammatory activation, and nitric oxide-cyclic guanosine monophosphate (NO-cGMP) pathway are involved in the pathophysiology of heart failure. Metabolic alterations have been studied in the myocardium of heart failure (HF) patients; alterations in ketone body and amino acid/protein metabolism have been described in patients affected by HF, as well as…
Source: Heart Failure ReviewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1The place of vericiguat in the landscape of treatment for heart failure with reduced ejection fraction - Heart Failure Reviews - 3 year(s) ago
The significant morbidity and mortality associated with heart failure with reduced (HFrEF) or preserved ejection fraction (HFpEF) justify the search for novel therapeutic agents. The nitric oxide (NO)āsoluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) pathway plays an important role in the regulation of cardiovascular function. This pathway is disrupted in HF resulting in…
Source: Heart Failure ReviewsCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Advanced cardiovascular multimodal imaging and aortic stenosis - Heart Failure Reviews - 3 year(s) ago
Aortic valve stenosis has become the most common valvular heart disease on account of aging population and increasing life expectancy. Echocardiography is the primary diagnosis tool for this, but it still has many flaws. Therefore, advanced cardiovascular multimodal imaging techniques are continuously being developed in order to overcome these limitations. Cardiac magnetic resonance imaging (CMR)…
Source: Heart Failure ReviewsCategories: Cardiologists, Latest HeadlinesTweet
šhttps://t.co/BIvdVJXja0